Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 14 min 5 sec ago

NuVasive Appoints Jason D. Hanson as Executive Vice President, Strategy, Corporate Development and General Counsel

Tue, 12/01/2015 - 13:32
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that Jason D. Hanson is join...
Devices, Orthopaedic, Neurosurgery, Personnel
NuVasive, Maximum Access Surgery, spine surgery

SomaLogic Announces College of American Pathologists (CAP) Accreditation of Its CLIA Laboratory

Tue, 12/01/2015 - 13:27
Novel SOMAmer(R) Reagent-Based Tests to Be Offered From CMS-Registered Testing Facility BOULDER, CO--(Healthcare Sales & Marketing Network) - SomaLogic, Inc. announced today that its SomaLogic Clinical Laboratory (CLIA laboratory) has been registered wi...
Diagnostics, Regulatory
SomaLogic, Wellness Chip

Roche And Upsher-Smith Announce License Agreement To Develop Novel VAP-1 Inhibitor

Tue, 12/01/2015 - 13:19
MAPLE GROVE, Minn. and BASEL, Switzerland, Dec. 1, 2015 -- (Healthcare Sales & Marketing Network) -- Roche and Upsher-Smith Laboratories, Inc. (Upsher-Smith), through its wholly-owned UK subsidiary Proximagen Ltd., today announced a worldwide agreement fo...
Biopharmaceuticals, Licensing
Upsher-Smith Laboratories, Proximagen, Roche Group, VAP-1 inhibitor

Boston Scientific Receives FDA Approval And CE Mark For AngioJet(TM) ZelanteDVT(TM) Thrombectomy Catheter

Mon, 11/30/2015 - 20:34
Catheter used to treat deep vein thrombosis to be commercialized in U.S. and Europe MARLBOROUGH, Mass., Nov. 30, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (BSX) has received United States (U.S.) Food and Drug Administration (F...
Devices, Interventional, FDA, Regulatory
Boston Scientific, AngioJet, ZelanteDVT, thrombectomy catheter

New Distribution Agreement Between Medline and Avamere Health Services Focuses on Readmissions Prevention and Clinical Education

Mon, 11/30/2015 - 20:31
Avamere’s entities will have access to programs like abaqis and Medline University to help enhance clinical outcomes MUNDELEIN, Ill.--(Healthcare Sales & Marketing Network)--Avamere Health Services, which provides a range of services to seniors in over ...
Devices, Distribution
Medline, Avamere Health Services

St. Jude Medical Announces European Launch of the World’s First and Only Upgradeable, Non-Rechargeable, Burst-Enabled MR-Conditional SCS System

Mon, 11/30/2015 - 16:11
By prioritizing convenience, comfort and pain relief, the Proclaim™ Elite SCS System aims to shift patient focus from their chronic pain therapy toward their quality of life ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc....
Devices, Neurology, Product Launch
St. Jude Medical, Proclaim Elite, spinal cord stimulation, neuromodulation

Three-Year Follow-Up Data From Lombard Medical Aorfix(TM) PYTHAGORAS Pivotal Trial Presented at 42nd Annual VEITHsymposium(TM)

Mon, 11/30/2015 - 13:18
Longer-Term Positive Outcomes in Abdominal Aortic Aneurysm Patients With Standard and Challenging Anatomies Reinforce the Broad Clinical Value of Aorfix IRVINE, Calif., Nov. 30, 2015 -- (Healthcare Sales & Marketing Network) -- Lombard Medical, Inc. (EV...
Devices, Interventional
Lombard Medical, EVAR , AAA, PYTHAGORAS, Aorfix

Elbit Imaging Ltd. Announces That InSightec's Exablate Neuro System Has Been Approved by the Korean Ministry of Food and Drug Safety

Mon, 11/30/2015 - 13:11
TEL AVIV, Israel, November 30, 2015 -- (Healthcare Sales & Marketing Network) -- Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today that it was informed by InSightec Ltd. ("InSightec"), that t...
Devices, Neurology, Regulatory
Elbit Imaging, InSightec, Exablate Neuro

OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors

Mon, 11/30/2015 - 13:06
IRVINE, Calif. and REHOVOT, Israel, Nov. 30, 2015 -- (Healthcare Sales & Marketing Network) -- OticPharma, Ltd., a privately held specialty pharmaceutical company focused on acquiring and developing innovative therapies for ear, nose, and throat (ENT) dis...
Biopharmaceuticals, Personnel
OticPharma, FoamOtic Externa, otitis externa

Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan

Mon, 11/30/2015 - 12:59
The Business Venture is Expected to Start Operating in the Second Calendar Quarter of 2016, and will Offer Patients and the Healthcare System the Portfolio of Teva’s High-Quality Generic Medicines and Takeda’s Long Listed Products Supported by the Compleme...
Biopharmaceuticals, Generics
Takeda Pharmaceutical, Teva Pharmaceutical

Proton Partners International to Fight Cancer with Elekta Radiotherapy Equipment

Mon, 11/30/2015 - 12:48
STOCKHOLM--(Healthcare Sales & Marketing Network)--Elekta (EKTA-B.ST) is to help Proton Partners International achieve its goal of creating hubs of excellence for advanced cancer treatment in the UK by providing the latest technology in radiotherapy. Pr...
Devices, Oncology
Elekta, linear accelerator, radiotherapy, radiosurgery, proton therapy

Lannett Completes Major Acquisition Of Kremers Urban Pharmaceuticals For $1.23 Billion

Fri, 11/27/2015 - 13:57
Acquisition creates key player in generic drug industry Strategic expansion, diversifies product portfolio, augments R&D pipeline PHILADELPHIA, Nov. 27, 2015 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (LCI) today announced th...
Biopharmaceuticals, Generic, Mergers & Acquisitions
Lannett Company, Kremers Urban Pharmaceuticals, UCB

EDDA Technology Introduces the Newly FDA-Cleared IQQA(R)-Guide Intra-operative Precision 3D Navigation for Minimally Invasive and Robotic Surgical Treatment

Wed, 11/25/2015 - 13:23
PRINCETON, N.J., Nov. 25, 2015 -- (Healthcare Sales & Marketing Network) -- EDDA Technology, a global leading provider in advanced imaging-guided precision treatment solutions, announced today that the company has received FDA clearance on IQQA®-Guide...
Devices, Surgery, FDA
EDDA Technology, IQQA-Guide, 3D navigation

Pfizer Receives European Approval to Expand Use of XALKORI(R) (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer

Wed, 11/25/2015 - 13:15
NEW YORK--(Healthcare Sales & Marketing Network)--Pfizer Inc. (PFE) today announced that the European Commission has approved a label update to expand use of XALKORI® (crizotinib) to first-line treatment of adults with anaplastic lymphoma kinase (ALK)-...
Biopharmaceuticals, Oncology, Regulatory
Pfizer, XALKORI, crizotinib, NSCLC, ALK-positive

Elekta: Karolinska University Hospital to Purchase Elekta’s Leksell Gamma Knife Icon

Wed, 11/25/2015 - 13:08
New System is Most Precise Stereotactic Radiosurgery System on the Market STOCKHOLM--(Healthcare Sales & Marketing Network)--By acquiring Elekta’s (EKTA-B.ST) latest generation intracranial stereotactic radiosurgery system, Leksell Gamma Knife® Icon...
Devices, Oncology, Neurosurgery
Elekta, Leksell, Gamma Knife Icon, radiosurgery, radiotherapy

DILON Diagnostics and GE Healthcare announce a global distribution agreement for the Discovery NM750b Molecular Breast Imaging system

Tue, 11/24/2015 - 19:46
Expanding the reach of Molecular Breast Imaging NEWPORT NEWS, Va., Nov. 24, 2015 -- (Healthcare Sales & Marketing Network) -- DILON Diagnostics and GE Healthcare are pleased to announce that they have signed an agreement for DILON to distribute GE's Di...
Devices, Distribution, Oncology
Dilon Technologies, DILON Diagnostics, GE Healthcare, NM750b Breast Imaging

European Commission Approves Reconciliation of Indications for nivolumab Under the Opdivo(R) European Marketing Authorization Application

Tue, 11/24/2015 - 13:48
Innovative regulatory approach enabled simultaneous review of nivolumab for two indications, expediting availability to patients PRINCETON, N.J.--(Healthcare Sales & Marketing Network)--Bristol-Myers Squibb Company (BMY) today announced that the Europea...
Biopharmaceuticals, Oncology, Regulatory
Bristol-Myers Squibb, Opdivo, nivolumab, melanoma, NSCLC

Bristol-Myers Squibb Announces U.S. Food and Drug Administration Approval for Opdivo (nivolumab) as a Single Agent for the Treatment of Patients with Previously Untreated BRAF Wild-Type Advanced Melanoma

Tue, 11/24/2015 - 13:39
First and only PD-1 immune checkpoint inhibitor approved as a single agent for first-line use in advanced BRAF wild-type melanoma Approval based on Phase 3 trial, CheckMate -066, which demonstrated superior overall survival vs. dacarbazine in first-lin...
Biopharmaceuticals, Oncology, FDA
Bristol-Myers Squibb, Opdivo, nivolumab, melanoma

Avita Medical Expands Commercial Reach for ReCell(R) in Wound Care Market With the Appointment of Distributors in France and the UK

Tue, 11/24/2015 - 13:28
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Healthcare Sales & Marketing Network) - Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that it has enter...
Regenerative Medicine, Wound Care, Distribution
Avita Medical, Medical Z, Ideal Medical Solutions, RECELL

European Commission Approves Amgen's BLINCYTO(R) (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia

Tue, 11/24/2015 - 13:22
BLINCYTO First Bispecific T Cell Engager (BiTE®) Antibody Construct Approved in European Union THOUSAND OAKS, Calif., Nov. 24, 2015 -- (Healthcare Sales & Marketing Network) -- Amgen (AMGN) today announced that the European Commission (EC) has gran...
Biopharmaceuticals, Oncology, Regulatory
Amgen, BLINCYTO, blinatumomab, acute lymphoblastic leukemia

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong